MYC and hepatocellular carcinoma: Previous evidence shows that HNF4α expression is diminished in hepatocellular carcinoma [20, 32–34], and loss of HNF4α leads to increased hepatocyte proliferation and promotion of diethylnitrosamine-induced hepatic tumors secondary to aberrant c-Myc activation [26].